4 Dividend Stocks That Give You a Clean Taste

Published Mon, 16 Jan 2012 20:23 CET by TopYields.nl


Introduction
Since I like to take good care of my teeth, I use mouthwash after brushing. While gargling, I was annoyed that every time I screwed the cap back on the bottle of Listerine® (I drink from the cap, yes), a little bit of mouthwash dripped from the cap on the bottle and the shelf, making it all very sticky. The previous bottle of mouthwash I used was Elmex Sensitive. For some of you an unknown brand maybe, but they really did something very clever: they made a little drinking tube inside the cap! Lo and behold, no more mouthwash dripping out, no more sticky bottles!
What does this have to do with dividend investing? Well... nothing really. But it gave me the idea to take a look at the companies behind all those bottles of mouthwash and see how they're doing, dividend-wise. So here we go.

How to invest in a clean taste?
Since this website is about dividend investing, the focus will be on stocks paying out dividend. Luckily, most producers of mouthwash are well-known companies and listed on the New York Stock Exchange: Colgate Palmolive (NYSE: CL), GlaxoSmithKline (NYSE: GSK), Jonhson & Johnson (NYSE: JNJ) and Procter & Gamble (NYSE: PG). All companies except GlaxoSmithKline are also S&P 500 Dividend Aristocrats.

Colgate Palmolive
Colgate Palmolive is owner of the GABA Group, which produces Aronal, Elmex and Meridol mouth-/dental rinses in Therwil, Switzerland. Colgate Palmolive had a net income of USD 2.5 billion in the last 12 months and has paid uninterrupted dividends on its common stock since 1895 and increased payments to common shareholders every year for 48 years.

GlaxoSmithKline
GSK produces mouthwash under the name of Astring-O-Sol, made famous by model Joey Eastwood in the kissing booth TV commercial. GSK had a net income of GBP 3.3 billion (~USD 5 billion) in the last 12 months.
The graphs below show the Earnings Per Share (EPS) and Dividend Per Share of GSK.

GlaxoSmithKline EPS and Dividend per Share Graphs

Jonhson & Johnson
In 2006, Listerine® became a JNJ product with the acquiring of Pfizer Consumer Healthcare. Listerine® Antiseptic was created in 1879, making it the first-ever antiseptic mouthwash. JNJ is the world's sixth-largest consumer health company with a net income of USD 64 billion in the last 12 months. The JNJ stock has seen 49 consecutive years of dividend increases.

Procter & Gamble
Oral-B (since acquiring Gillette in 2005) and Scope are brands of mouthwash made by Procter & Gamble. P&G is the largest consumer goods company with a net income of USD 11.8 billion in 2011 and has paid uninterrupted dividends on its stock since 1890 and increased payments to shareholders every year for 54 years.

Name Dividend growth rate (5 years) EPS growth (5 years)
Colgate Palmolive 12.83% 12.17 USD
GlaxoSmithKline 8.12% -17.22 GBP
Jonhson & Johnson 10.60% 7.35 USD
Procter & Gamble 11.37% 10.18 USD


Disclosure: at the moment of writing, TopYields doesn't own any of the stocks mentioned.
Stock name Dividend Yield
Glaxosmithkline 5.05
Procter & Gamble 2.99
Johnson & Johnson 2.52
Colgate Palmolive 2.23

Articles featuring Glaxosmithkline (GSK):

5%+ Dividend Yield Portfolio: Back To Winning Ways (March 2017 Review)

Outlook "May you live in interesting times" supposedly goes a Chinese proverb. However, this isn't a phrase of encouragement but instead a curse that the target may not know peace and tranquility. Well these are indeed interesting times with rising markets despite rising interest rates (so much for don't fight the Fed) and don't even get me started on politics. But March's meager market performance (S&P 500 returns of 0.34%) may be a sign of trouble ahead... Read more

The Most Popular European Dividend Stocks

In my last article, "The Most Popular Stocks In Dividend-Focused Mutual Funds," I surveyed 21 dividend-focused mutual funds to discover which U.S. dividend stocks are the most popular among active mutual fund managers. In the comment stream of that article, I received feedback that some folks would like to see the analysis repeated for European stocks. That sounded interesting to me as well! One note before we dive in - as with my U.S. analysis, this European study does not... Read more

5%+ Dividend Yield Portfolio: New Rules For FOMO (February 2017 Review)

Outlook As regular readers know, my crystal ball is cloudy at best. However, since the election, my prognostication skills have been particularly poor as the 'animal spirits' of the market have been ignited in a way that has truly perplexed me. Sure, I am glad that my portfolio is up in 2017 and up almost 20% in the trailing 12 months (and my dividend stream is more solid than ever), but it is hard to not suffer from FOMO ("fear of missing out") when the market is up 14%... Read more

Lanny's January Dividend Income Summary

Wow, here we are everyone! We are 1/12th in the books and the engine is starting to make progress for 2017. It has been one wild month, being in the busy season - these are the days that last forever, but fly by at the same time. When you are working 60-80 hours per week, it feels like there is so much to do and going on that you can't seem to keep up, but yet, your days are longer, still yearning for more hours in the day. Now that January is in the books, however, that means that one... Read more

5%+ Dividend Yield Portfolio: Taking Profits As Market Valuations Flash Warnings (Jan 2017 Review)

Review and Outlook It's been a solid start to the year as the S&P 500's return of 1.9% was almost mirrored by my 1.5% return. After the dramatic returns of November and December, it makes sense to me that the markets would take a breather before deciding on the next move. No Trump talk from me this month - not because it isn't relevant, but because: 1) he is already the subject of thousands of mentions on Seeking Alpha, and 2) no one has any idea what is going to happen... Read more